Charles River Laboratories | CRL - Przychody Ze Sprzedaży

Cena Akcji
169.80
Dzienna Zmiana
2.06 1.23%
Miesięcznie
2.36%
Rocznie
48.09%
Q2 Prognozy TE
166.17




Obroty Zmiana Data
Agilent USD 1.8B 63M 2025-12
Align Technology USD 1.05B 54.3M 2025-12
Bio-Rad Laboratories USD 693.2M 40.2M 2025-12
Bruker USD 977.2M 116.7M 2025-12
Cardinal Health USD 65.63B 1.63B 2025-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Cigna USD 72.47B 2.77B 2025-12
Concord Medical Services Hldg CNY 200.61M 83.9M 2025-06
CVS Health USD 105.7B 2.8B 2025-12
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 961M 57M 2025-12
Elevance Health USD 49.5B 200M 2026-03
Galapagos EUR 900.82M 835.52M 2025-12
Humana USD 32.52B 130M 2025-12
Illumina USD 1.16B 80M 2025-12
Incyte USD 1.51B 140M 2025-12
Intrexon USD 717K 511K 2024-06
IQVIA Holdings USD 4.36B 260M 2025-12
Laboratory Of America USD 3.52B 40M 2025-12
Lonza CHF 3.58B 63M 2025-06
McKesson USD 106.16B 3.01B 2025-12
Merck EUR 5.25B 70M 2025-12
Mettler Toledo International USD 1.13B 100M 2025-12
Novartis USD 13.86B 50M 2025-12
Pfizer USD 17.58B 880M 2025-12
Quest Diagnostics USD 2.9B 90M 2026-03
Revvity USD 772.06M 73.06M 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
United Therapeutics USD 790.2M 9.3M 2025-12
UnitedHealth USD 111.7B 1.5B 2026-03
Veradigm USD 142.52M 9.38M 2022-12
Waters USD 932M 132M 2025-12
West Pharmaceutical Services USD 844.9M 39.9M 2026-03